Cargando…

Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera)

Hepatitis C and polycythemia vera (PV) co-existence is not rare; it has been reported in the literature. Treatment with interferon (IFN) has been used to treat both conditions; however, the use of IFN in concomitant hepatitis C infection with PV and its outcome are rarely described in the literature...

Descripción completa

Detalles Bibliográficos
Autores principales: Shwaylia, Hawraa, Ali, Elrazi, Yassin, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255747/
https://www.ncbi.nlm.nih.gov/pubmed/34248550
http://dx.doi.org/10.1159/000515782
_version_ 1783717972003520512
author Shwaylia, Hawraa
Ali, Elrazi
Yassin, Mohamed A.
author_facet Shwaylia, Hawraa
Ali, Elrazi
Yassin, Mohamed A.
author_sort Shwaylia, Hawraa
collection PubMed
description Hepatitis C and polycythemia vera (PV) co-existence is not rare; it has been reported in the literature. Treatment with interferon (IFN) has been used to treat both conditions; however, the use of IFN in concomitant hepatitis C infection with PV and its outcome are rarely described in the literature. Here, we report a 56-years-old male patient with hepatitis C virus infection and PV, who was treated with IFN for his chronic hepatitis C, which resulted in significant improvement of HB as well as normalization of his bone marrow and eradication of the clone (Jak2 V617F).
format Online
Article
Text
id pubmed-8255747
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-82557472021-07-09 Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera) Shwaylia, Hawraa Ali, Elrazi Yassin, Mohamed A. Case Rep Oncol Case Report Hepatitis C and polycythemia vera (PV) co-existence is not rare; it has been reported in the literature. Treatment with interferon (IFN) has been used to treat both conditions; however, the use of IFN in concomitant hepatitis C infection with PV and its outcome are rarely described in the literature. Here, we report a 56-years-old male patient with hepatitis C virus infection and PV, who was treated with IFN for his chronic hepatitis C, which resulted in significant improvement of HB as well as normalization of his bone marrow and eradication of the clone (Jak2 V617F). S. Karger AG 2021-06-11 /pmc/articles/PMC8255747/ /pubmed/34248550 http://dx.doi.org/10.1159/000515782 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Shwaylia, Hawraa
Ali, Elrazi
Yassin, Mohamed A.
Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera)
title Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera)
title_full Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera)
title_fullStr Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera)
title_full_unstemmed Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera)
title_short Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera)
title_sort interferon-alpha 2-a and its dual effect in treating two diseases (hepatitis c and polycythemia vera)
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255747/
https://www.ncbi.nlm.nih.gov/pubmed/34248550
http://dx.doi.org/10.1159/000515782
work_keys_str_mv AT shwayliahawraa interferonalpha2aanditsdualeffectintreatingtwodiseaseshepatitiscandpolycythemiavera
AT alielrazi interferonalpha2aanditsdualeffectintreatingtwodiseaseshepatitiscandpolycythemiavera
AT yassinmohameda interferonalpha2aanditsdualeffectintreatingtwodiseaseshepatitiscandpolycythemiavera